See more : NKGen Biotech, Inc. Common Stock (NKGN) Income Statement Analysis – Financial Results
Complete financial analysis of Inovalon Holdings, Inc. (INOV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Inovalon Holdings, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- eole Inc. (2334.T) Income Statement Analysis – Financial Results
- Evolution Mining Limited (CAHPF) Income Statement Analysis – Financial Results
- Tiger Reef, Inc. (TGRR) Income Statement Analysis – Financial Results
- PT Hanjaya Mandala Sampoerna Tbk (HMSP.JK) Income Statement Analysis – Financial Results
- Nissin Shoji Co.,Ltd. (7490.T) Income Statement Analysis – Financial Results
Inovalon Holdings, Inc. (INOV)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: http://www.inovalon.com
About Inovalon Holdings, Inc.
Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, a cloud-based platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately 988,000 physicians; 522,000 clinical facilities; and approximately 314 million individuals and 53 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 667.52M | 642.41M | 527.68M | 449.36M | 427.59M | 437.27M | 361.54M | 295.80M | 300.28M | 239.69M |
| Cost of Revenue | 167.82M | 167.81M | 144.83M | 151.05M | 159.17M | 146.14M | 112.76M | 120.05M | 101.19M | 102.70M |
| Gross Profit | 499.70M | 474.60M | 382.85M | 298.31M | 268.42M | 291.13M | 248.78M | 175.74M | 199.09M | 136.99M |
| Gross Profit Ratio | 74.86% | 73.88% | 72.55% | 66.39% | 62.78% | 66.58% | 68.81% | 59.41% | 66.30% | 57.15% |
| Research & Development | 33.50M | 33.69M | 28.64M | 27.38M | 29.15M | 22.33M | 23.13M | 21.19M | 15.50M | 14.86M |
| General & Administrative | 216.62M | 200.76M | 205.04M | 149.95M | 137.28M | 115.03M | 88.57M | 80.64M | 72.66M | 63.18M |
| Selling & Marketing | 62.94M | 62.41M | 45.53M | 34.10M | 27.08M | 14.68M | 7.14M | 5.95M | 6.79M | 6.75M |
| SG&A | 279.56M | 263.17M | 250.57M | 184.05M | 164.35M | 129.71M | 95.71M | 86.59M | 79.45M | 69.94M |
| Other Expenses | 114.93M | 108.25M | 96.73M | 53.09M | 37.28M | 22.63M | 19.88M | 15.52M | 12.90M | 11.23M |
| Operating Expenses | 427.99M | 405.11M | 375.94M | 264.52M | 230.79M | 174.68M | 138.72M | 123.30M | 107.85M | 96.02M |
| Cost & Expenses | 595.81M | 572.92M | 520.76M | 415.57M | 389.95M | 320.82M | 251.48M | 243.35M | 209.04M | 198.72M |
| Interest Income | 479.00K | 2.24M | 2.18M | 5.43M | 5.79M | 3.00M | 6.00K | 9.00K | 11.00K | 10.00K |
| Interest Expense | 56.18M | 65.83M | 50.90M | 6.23M | 5.07M | 4.42M | 1.34M | 79.00K | 129.00K | 62.00K |
| Depreciation & Amortization | 114.93M | 108.25M | 96.73M | 53.09M | 37.28M | 22.63M | 19.88M | 15.52M | 12.90M | 11.23M |
| EBITDA | 186.56M | 179.96M | 94.07M | 91.90M | 81.25M | 141.76M | 129.95M | 67.97M | 104.15M | 52.21M |
| EBITDA Ratio | 27.95% | 28.01% | 17.83% | 20.45% | 19.00% | 32.42% | 35.94% | 22.98% | 34.68% | 21.78% |
| Operating Income | 71.71M | 69.49M | 6.92M | 33.79M | 37.63M | 116.46M | 110.06M | 52.45M | 91.24M | 40.97M |
| Operating Income Ratio | 10.74% | 10.82% | 1.31% | 7.52% | 8.80% | 26.63% | 30.44% | 17.73% | 30.38% | 17.09% |
| Total Other Income/Expenses | -56.25M | -63.61M | -60.47M | -1.20M | 1.27M | -1.75M | -1.33M | -70.00K | -118.00K | -52.00K |
| Income Before Tax | 15.46M | 5.88M | -53.56M | 32.59M | 38.90M | 114.71M | 108.73M | 52.38M | 91.12M | 40.92M |
| Income Before Tax Ratio | 2.32% | 0.91% | -10.15% | 7.25% | 9.10% | 26.23% | 30.07% | 17.71% | 30.34% | 17.07% |
| Income Tax Expense | -7.12M | -1.90M | -14.39M | -2.23M | 11.80M | 48.65M | 43.38M | 19.66M | 35.96M | 15.99M |
| Net Income | 22.58M | 7.78M | -39.16M | 34.82M | 27.10M | 66.06M | 65.35M | 32.72M | 55.16M | 24.93M |
| Net Income Ratio | 3.38% | 1.21% | -7.42% | 7.75% | 6.34% | 15.11% | 18.08% | 11.06% | 18.37% | 10.40% |
| EPS | 0.15 | 0.05 | -0.27 | 0.24 | 0.18 | 0.45 | 0.53 | 1.47 | 2.48 | 1.12 |
| EPS Diluted | 0.15 | 0.05 | -0.27 | 0.24 | 0.18 | 0.45 | 0.53 | 1.47 | 2.48 | 1.12 |
| Weighted Avg Shares Out | 149.72M | 148.63M | 145.39M | 142.23M | 150.05M | 145.75M | 122.26M | 22.22M | 22.22M | 22.22M |
| Weighted Avg Shares Out (Dil) | 149.72M | 148.63M | 145.39M | 142.74M | 150.96M | 148.28M | 122.26M | 22.22M | 22.22M | 22.22M |
Pharmacy Leaders and Technology Innovators Convene Virtually November 8-9, 2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation into the Fairness of the Merger of Inovalon with Nordic Capital
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation into the Fairness of the Merger of Inovalon with Nordic Capital
Inovalon to Host Virtual Client Congress October 18-19, 2021
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates HOMB, KRA, EBMT, ESBK, INOV; Shareholders are Encouraged to Contact the Firm
INOVALON INVESTOR ALERT (INOV) - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Inovalon Holdings, Inc.
INOVALON INVESTOR ALERT (INOV) - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Inovalon Holdings, Inc.
CorEvitas and Inovalon Leverage Advanced Analytics to Deliver A Holistic View of the Patient
Shareholder Alert: Robbins LLP Announces Acquisition of Inovalon Holdings, Inc. (INOV) by Nordic Capital and Others (Private) May Not Be in Shareholders' Best Interests
Shareholder Alert: Robbins LLP Announces Acquisition of Inovalon Holdings, Inc. (INOV) by Nordic Capital and Others (Private) May Not Be in Shareholders' Best Interests
Source: https://incomestatements.info
Category: Stock Reports